Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Suppression of CD80 Expression by ICP22 Affects Herpes Simplex Virus Type 1 Replication and CD8+IFN-γ+Infiltrates in the Eyes of Infected Mice but Not Latency Reactivation

Journal of Virology(2021)10.1128/jvi.01036-21Source: DataRank Database

Suppression of CD80 Expression by ICP22 Affects Herpes Simplex Virus Type 1 Replication and CD8+IFN-γ+Infiltrates in the Eyes of Infected Mice but Not Latency Reactivation is a research paper published in Journal of Virology (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.14)OA: hybridTopics (70)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Shaohui Wang ORCID,Ujjaldeep Jaggi ORCID,Jack Yu ORCID,Homayon Ghiasi ORCID,Harry H. Matundan ORCID

Live enrichment

PubMed:34287036 PMC:PMC8428405 OpenAlex:https://openalex.org/W3186914352

HHS | NIH | National Eye Institute

Grant: RO1EY026944

HHS | NIH | National Eye Institute

Grant: RO1EY029160

NEI NIH HHS

Grant: R01 EY026944

NEI NIH HHS

Grant: R01 EY029160

National Institutes of Health

Grant: 5R01EY029160-04

Ocular HSV: Mechanism of virus reactivation

National Institutes of Health

Grant: 2R01EY026944-05

Therapeutic control of HSK by CD80

FWCI

1.14

Citation Percentile

0.8%

Influential Citations

Citation Trend

2021

2022

2024

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/jvi.01036-21

HYBRIDhttps://doi.org/10.1128/jvi.01036-21

publisherhttps://doi.org/10.1128/jvi.01036-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/JVI.01036-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34287036

Fields of Study

Herpesvirus Infections and TreatmentsImmunotherapy and Immune ResponsesCytomegalovirus and herpesvirus researchMedicineBiology03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsCell LineCorneaDendritic CellsHumansInterferon-gammaMice, Inbred BALB CPromoter Regions, GeneticRecombinant ProteinsTearsVirus ActivationVirus ReplicationCD4-Positive T-LymphocytesUp-RegulationKeratitis, HerpeticVirus LatencyImmediate-Early ProteinsB7-1 AntigenHerpesvirus 1, HumanCD8-Positive T-LymphocytesMiceImmune Evasion

Keywords

Herpes simplex virusBiologyVirusMolecular biologyCD80Viral replicationVirologyRecombinant DNACytotoxic T cellIn vitroBiochemistryGeneCD40TransfectionLuciferaseCorneaMappingHSV-1Virus replicationIcp22Cd80 PromoterCD4-Positive T-LymphocytesMice, Inbred BALB CDendritic CellsHerpesvirus 1, HumanCD8-Positive T-LymphocytesRecombinant ProteinsCell LineImmediate-Early ProteinsUp-RegulationInterferon-gammaMiceTearsB7-1 AntigenKeratitis, HerpeticPathogenesis and ImmunityAnimalsHumansVirus ActivationPromoter Regions, GeneticImmune Evasion

Sustainable Development Goals

SDG 3: 3. Good health